| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1045016691 |
| P356 | DOI | 10.1186/1472-6963-13-313 |
| P932 | PMC publication ID | 3751761 |
| P698 | PubMed publication ID | 23945045 |
| P5875 | ResearchGate publication ID | 255954548 |
| P50 | author | Helen Marshall | Q60584190 |
| Michael S Gold | Q105724594 | ||
| P2093 | author name string | Annette Braunack-Mayer | |
| Peter Baghurst | |||
| Adriana Parrella | |||
| P2860 | cites work | The Vaccine Safety Datalink: a model for monitoring immunization safety | Q27010367 |
| Annual report: surveillance of adverse events following immunisation in Australia, 2009 | Q30396460 | ||
| Assessing vaccine safety communication with healthcare providers in a large urban county | Q30407586 | ||
| Parental views on vaccine safety and future vaccinations of children who experienced an adverse event following routine or seasonal influenza vaccination in 2010. | Q30417277 | ||
| Annual report: Surveillance of adverse events following immunisation in Australia, 2011. | Q30426079 | ||
| Use of the Australian Childhood Immunisation Register for vaccine safety data linkage. | Q33568217 | ||
| Adverse events and vaccination-the lack of power and predictability of infrequent events in pre-licensure study. | Q34189164 | ||
| Physicians' attitudes and adverse drug reaction reporting : a case-control study in Portugal. | Q52805751 | ||
| Improving global monitoring of vaccine safety: a quantitative analysis of adverse event reports in the WHO Adverse Reactions Database. | Q53221184 | ||
| Beyond blame: cultural barriers to medical incident reporting. | Q53306437 | ||
| In the heat of a signal: responding to a vaccine safety signal for febrile seizures after 2010-11 influenza vaccine in young children, United States | Q64126242 | ||
| Withdrawal of rotavirus vaccine recommendation | Q73217916 | ||
| Surveillance of vaccine safety: comparison of parental reports with routine surveillance and a clinical trial | Q83798645 | ||
| What should an ideal vaccine postlicensure safety system be? | Q84615703 | ||
| Pharmacy students' knowledge and perceptions about pharmacovigilance in Malaysian public universities | Q35126161 | ||
| Barriers to incident reporting in a healthcare system | Q35524881 | ||
| The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective | Q35624610 | ||
| The involvement of nurses in reporting suspected adverse drug reactions: experience with the meningococcal vaccination scheme | Q35825558 | ||
| Reporting of adverse events following immunization in Australia | Q36090755 | ||
| Under-reporting of adverse drug reactions : a systematic review | Q36475336 | ||
| Reporting vaccine-associated adverse events | Q36479586 | ||
| A survey on the knowledge, attitude and the practice of pharmacovigilance among the health care professionals in a teaching hospital in northern India | Q36622521 | ||
| Determinants of under-reporting of adverse drug reactions: a systematic review. | Q37365382 | ||
| Monitoring and assessing vaccine safety: a European perspective | Q37724854 | ||
| Surveillance of adverse effects following vaccination and safety of immunization programs | Q37823382 | ||
| Surveillance of adverse events following immunisation: the model of SAEFVIC, Victoria. | Q38012774 | ||
| Continuing decline in service delivery for family physicians: is the malpractice crisis playing a role? | Q39744430 | ||
| A summer school on vaccinology: Responding to identified gaps in pre-service immunisation training of future health care workers | Q39915826 | ||
| Improving global monitoring of vaccine safety: a survey of national centres participating in the WHO Programme for International Drug Monitoring | Q42003512 | ||
| Who is unlikely to report adverse events after vaccinations to the Vaccine Adverse Event Reporting System (VAERS)? | Q42266126 | ||
| Adverse events following immunization (AEFI) with the novel influenza a (H1N1) 2009 vaccine: findings from the national registry of all vaccine recipients and AEFI and the passive surveillance system in South Korea. | Q43171994 | ||
| The role of the Vaccine Adverse Event Reporting system (VAERS) in monitoring vaccine safety | Q43969479 | ||
| The lack of knowledge about the voluntary reporting system of adverse drug reactions as a major cause of underreporting: direct survey among health professionals | Q45351535 | ||
| Physician response to patient reports of adverse drug effects: implications for patient-targeted adverse effect surveillance. | Q45937737 | ||
| Two programs focused on mentoring and training in vaccine safety | Q48574252 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 313 | |
| P577 | publication date | 2013-08-15 | |
| P1433 | published in | BMC Health Services Research | Q4835946 |
| P1476 | title | Healthcare providers' knowledge, experience and challenges of reporting adverse events following immunisation: a qualitative study | |
| P478 | volume | 13 |
| Q34438478 | Assessment of attitudes towards adverse events following immunization with oral poliovirus vaccine: a pilot study among high school students of Kinshasa, the Democratic Republic of Congo. |
| Q50682460 | Awareness and utilization of reporting pathways for adverse events following immunization: online survey among pediatricians in Russia and Germany. |
| Q91580140 | Barriers to healthcare workers reporting adverse events following immunization in four regions of Ghana |
| Q35921383 | Blame the Patient, Blame the Doctor or Blame the System? A Meta-Synthesis of Qualitative Studies of Patient Safety in Primary Care |
| Q35886491 | Consumer reporting of adverse events following immunization |
| Q34033938 | Consumer reporting of adverse events following immunization (AEFI): identifying predictors of reporting an AEFI. |
| Q104078151 | Efficacy of m-Health for the detection of adverse events following immunization - The stimulated telephone assisted rapid safety surveillance (STARSS) randomised control trial |
| Q38877088 | Evaluation of 'SAEFVIC', A Pharmacovigilance Surveillance Scheme for the Spontaneous Reporting of Adverse Events Following Immunisation in Victoria, Australia. |
| Q36655574 | Improving community based AEFI (Adverse Events Following Immunization) reporting rate through telephone "beep" in a Cameroon health district: a randomized field trial |
| Q64118850 | Knowledge and Perceptions of Adverse Events Following Immunization among Healthcare Professionals in Africa: A Case Study from Ghana |
| Q37548127 | Knowledge, Perceptions, and Practice of Nurses on Surveillance of Adverse Events following Childhood Immunization in Nairobi, Kenya |
| Q33824021 | Knowledge, practice and approaches of health professionals to adverse events following immunization and their reporting in Albania |
| Q92985041 | On the contextual nature of vaccine safety monitoring: Adverse events reporting after HPV-vaccination in Denmark, 2015 |
| Q26853438 | WHO Efforts to Promote Reporting of Adverse Events and Global Learning |
Search more.